{{Drugbox
| IUPAC_name = 1-(9''H''-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
| image = Carazolol.svg
| width = 150

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|carazolol}}
| legal_status =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 57775-29-8
| ATCvet = yes
| ATC_prefix = C07
| ATC_suffix = AA90
| PubChem = 71739
| IUPHAR_ligand = 569
| ChEMBL = 324665
| ChemSpiderID = 64783
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 29PW75S82A

<!--Chemical data-->
| C=18 | H=22 | N=2 | O=2 
| molecular_weight = 298.38
| smiles = OC(CNC(C)C)COc3cccc2c3c1c(cccc1)n2
}}

'''Carazolol''' is a high affinity [[Receptor antagonist|antagonist]]/partial inverse agonist (also referred to as a [[beta blocker]]) of the β-[[adrenergic receptor]].<ref name="pmid41147">{{cite journal | vauthors = Innis RB, Corrēa FM, Synder SH | title = Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes | journal = Life Sci. | volume = 24 | issue = 24 | pages = 2255–64 | year = 1979 | pmid = 41147 | doi = 10.1016/0024-3205(79)90102-4 }}</ref>

== References ==
{{Reflist}}

==External links==
* {{MeshName|Carazolol}}

[[Category:Carbazoles]]
[[Category:Phenol ethers]]
[[Category:Alcohols]]


{{cardiovascular-drug-stub}}